PHI 86/25 Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2025

The Prescribed List of Medical Devices and Human Tissue Products takes effect on 1 November 2025.

Date published:
PHI circular type:
Prescribed List announcement

The Delegate for the Minister of Health and Aged Care has made the Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 2) 2025 (the MDHTP Rules).

The MDHTP Rules were registered on the Federal Register of Legislation on 23 October 2025 and replace the Private Health Insurance (Medical Devices and Human Tissue Products) Amendment Rules (No. 2) 2025.

See the Prescribed List.

Changes effected in the MDHTP Rules

The MDHTP Rules give effect to all changes resulting from completion of the Prescribed List applications (new, amendment, expansion, compression, deletion, and transfer applications).

Incorrectly listed billing codes

Some billing codes on the PL were identified as listed in incorrect groupings (meaning category-subcategory-group-subgroup-suffix). This means that the devices did not have the attributes to fit in the groupings they were listed in.

The department sought advice and contacted the sponsors of these billing codes to seek required information for their respective devices. All available information was assessed and further advice was sought when required.

Following detailed consideration of the above, decisions were made to correct the details of the billing codes in the 1 November 2025.

Other

Minor edits to sections 17, 18 and 19 to clarify applicable listing criteria and requirements about formal notification of delegate decisions for reasons other than those outlined in sections 17 and 18.